Options X Abstract Submission

Key Details for Presenters

Posters 1.5m (h) x 0.9m (w) Portrait                   

Oral presentation widescreen (16:9)


Abstract Submission closed 15 April: notification by 31 May

Late breaker abstracts submission closed 15 July: notification by 31 July

Guidelines - Summary

  1. Category Submission
    • Abstracts can be submitted into 4 categories: Virology and Pathogenesis, Clinical Science, Public Health and Co-Infection
      Virology & Pathogenesis Clinical Science Public Health Co-infection                
      Viral Replication Avian & Zoonotic Influenza- human infections Disease burden & severity Co-infection models
      Cellular & Molecular Virology Clinical Trials - Treatment and prevention Epidemiology & Transmission Bacterial Co-infections with Influenza
      Emerging Influenza Viruses Diagnostics and disease markers Pandemic Preparedness Viral Co-infections with Influenza
      Host-Pathogen Interactions Development of Human Disease Human Sero-Epidemiology studies  
      Immune response to Infection Special Populations - clinical aspects Surveillance & Forecasting  
      Influenza Evolution & Human Ecology Therapeutics - Antivirals Vaccine Efficacy / Effectiveness / Impact  
      Influenza Glycobiology Therapeutics - Immunomodulators, supportive care, others Non-pharmaceutical interventions - public health aspects  
      Next Gen / Universal Vaccines Clinical Trials - Study Designs, Clinical endpoints Pharmaco-economics, cost effectiveness studies  
      Non-Human Influenza Viruses Clinical Trials - Vaccines    
      Virus Pathogenesis & Transmission Non-Pharmaceutical Interventions - clinical aspects    
  2. Types of Submission Abstracts can be submitted for consideration for oral presentation and/or poster presenation. Those chosen for oral presentation will be required to present for 10 minutes followed by 2 minutes for discussion. For poster presentations, there will be a dedicated area for posters and dedicated poster sessions for authors to present their work.
  3. Confirmation  Upon submission of an abstract, the author will receive an automated acknowledgement via email. No acknowledgement indicates that the abstract has not been received. In this case, contact the Options X Abstract Team email: optionsxsg@acedaytons-direct.com OR telephone: +(65) 6379 5261  / +(65) 6379 5267

  4. Notification of Acceptance The presenting author of each accepted abstract will be notified by email. For abstract submitted by 15 April - notification will be sent out by 31 May 2019. For Late Breaking abstracts, notification will be sent by 31 July 2019.
  5. Publication
    Upon acceptance of the abstract, the presenting author must register for the conference to present at the oral session or poster presentation. Following registration, it is assumed that permission is granted for publication on the conference website. Full registration and payment is to be completed by 28 June 2019. Abstracts will be published as submitted.
  6. General Submission Guidelines
  • Abstract must be submitted via the conference website
  • Abstract must be in English only
  • To enable a comprehensive review, the abstract must include the following sections: Introduction, method, result, conclusion
  • Abstracts must be submitted before 15 April 2019 to be considered (Late breaking abstracts - 15 July 2019)
  • Abstracts may be edited up to the close of abstract submission, 15 April 2019 (Late breaking abstracts - 15 July 2019). Following the abstract submission deadline, no further editing will be permitted.
  • Abstracts will be reviewed solely on the basis of the data submitted in the abstract
  • STRUCTURE: The title must be brief, concise and in capital letters. The abstract body has a maximum of 300 words only. For each co-author, the affiliation, city and country should be listed. Please do not include references in the abstract.

Questions? Contact the Options X Abstract Team